Luan X - Search Results

1

Pretreatment Metabolic Parameters Measured by ¹⁸F-FDG PET to Predict the Pathological Treatment Response of HCC Patients Treated With PD-1 Inhibitors and Lenvatinib as a Conversion Therapy in BCLC Stage C.

Wang G, Zhang W, Chen J, Luan X, Wang Z, Wang Y, Xu X, Yao S, Guan Z, Tian J, Lu S, Xu B, Ma G. Wang G, et al. Among authors: luan x. Front Oncol. 2022 Jun 3;12:884372. doi: 10.3389/fonc.2022.884372. eCollection 2022. Front Oncol. 2022. PMID: 35719917 Free PMC article.

2

Multiparameter diagnostic model based on ¹⁸F-FDG PET metabolic parameters and clinical variables can differentiate nonmetastatic gallbladder cancer and cholecystitis.

Li C, Luan X, Bi X, Chen S, Pan Y, Zhang J, Han Y, Xu X, Wang G, Xu B. Li C, et al. Among authors: luan x. BMC Cancer. 2023 Feb 6;23(1):119. doi: 10.1186/s12885-023-10599-7. BMC Cancer. 2023. PMID: 36747196 Free PMC article.

3

Can ¹⁸F-PSMA-7Q PET/CT replace prostate biopsy for the diagnosis of prostate cancer?-A single-center retrospective study.

Liu Y, Niu S, Luan X, Zhang X, Liu J, Zhang J, Wang R, Xu B, Zhang X. Liu Y, et al. Among authors: luan x. Transl Androl Urol. 2023 Jan 30;12(1):83-89. doi: 10.21037/tau-22-813. Epub 2023 Jan 12. Transl Androl Urol. 2023. PMID: 36760865 Free PMC article.

4

The role of ¹⁸F-FDG PET in predicting the pathological response and prognosis to unresectable HCC patients treated with lenvatinib and PD-1 inhibitors as a conversion therapy.

Wang G, Zhang W, Luan X, Wang Z, Liu J, Xu X, Zhang J, Xu B, Lu S, Wang R, Ma G. Wang G, et al. Among authors: luan x. Front Immunol. 2023 May 5;14:1151967. doi: 10.3389/fimmu.2023.1151967. eCollection 2023. Front Immunol. 2023. PMID: 37215117 Free PMC article.

5

Multiparameter diagnostic model based on ¹⁸F-FDG positron emission tomography and serological examination for differentiating focal autoimmune pancreatitis from pancreatic ductal adenocarcinoma.

Wang G, Du L, Lu X, Chen S, Bi X, Zhang M, Luan X, Xu X, Zhang Z, Xu B, Yang J. Wang G, et al. Among authors: luan x. Quant Imaging Med Surg. 2023 Sep 1;13(9):5653-5663. doi: 10.21037/qims-23-88. Epub 2023 Jul 11. Quant Imaging Med Surg. 2023. PMID: 37711769 Free PMC article.

6

Metabolic parameters of pretreatment 2-[¹⁸F]fluoro-D-glucose positron emission tomography for prognosis in patients with gallbladder adenocarcinoma: a cohort study.

Li C, Dong Y, Pan Y, Han Y, Zhang J, Luan X, Liu J, Xu X, Guan Z, Wang G, Xu B. Li C, et al. Among authors: luan x. Quant Imaging Med Surg. 2024 Jan 3;14(1):604-617. doi: 10.21037/qims-23-1003. Epub 2024 Jan 2. Quant Imaging Med Surg. 2024. PMID: 38223061 Free PMC article.

7

Tumor angiogenesis at baseline identified by ¹⁸F-Alfatide II PET/CT may predict survival among patients with locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy.

Wei Y, Qin X, Liu X, Zheng J, Luan X, Zhou Y, Yu J, Yuan S. Wei Y, et al. Among authors: luan x. J Transl Med. 2022 Feb 2;20(1):63. doi: 10.1186/s12967-022-03256-3. J Transl Med. 2022. PMID: 35109866 Free PMC article. Clinical Trial.

8

¹⁸F-RGD PET/CT imaging reveals characteristics of angiogenesis in non-small cell lung cancer.

Li L, Zhao W, Sun X, Liu N, Zhou Y, Luan X, Gao S, Zhao S, Yu J, Yuan S. Li L, et al. Among authors: luan x. Transl Lung Cancer Res. 2020 Aug;9(4):1324-1332. doi: 10.21037/tlcr-20-187. Transl Lung Cancer Res. 2020. PMID: 32953507 Free PMC article.

9

¹⁸F-alfatide PET/CT may predict short-term outcome of concurrent chemoradiotherapy in patients with advanced non-small cell lung cancer.

Luan X, Huang Y, Gao S, Sun X, Wang S, Ma L, Teng X, Lu H, Yu J, Yuan S. Luan X, et al. Eur J Nucl Med Mol Imaging. 2016 Dec;43(13):2336-2342. doi: 10.1007/s00259-016-3505-3. Epub 2016 Sep 8. Eur J Nucl Med Mol Imaging. 2016. PMID: 27631310 Free PMC article.

10

Drug eruption and cutaneous metastasis in a patient with ALK-negative anaplastic large T-cell lymphoma after tislelizumab.

Su T, Luan X, Lu Y, Xu Y. Su T, et al. Among authors: luan x. Australas J Dermatol. 2024 Jun 19. doi: 10.1111/ajd.14337. Online ahead of print. Australas J Dermatol. 2024. PMID: 38895816 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,287 results

Search Page